BRNS
Price
$1.31
Change
-$0.07 (-5.07%)
Updated
Aug 6 closing price
Capitalization
52.84M
Earnings call today
TARA
Price
$3.11
Change
-$0.00 (-0.00%)
Updated
Aug 7, 10:55 AM (EDT)
Capitalization
119.99M
4 days until earnings call
Interact to see
Advertisement

BRNS vs TARA

Header iconBRNS vs TARA Comparison
Open Charts BRNS vs TARABanner chart's image
Barinthus Biotherapeutics
Price$1.31
Change-$0.07 (-5.07%)
Volume$32.49K
Capitalization52.84M
Protara Therapeutics
Price$3.11
Change-$0.00 (-0.00%)
Volume$100
Capitalization119.99M
BRNS vs TARA Comparison Chart in %
Loading...
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRNS vs. TARA commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRNS is a Buy and TARA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (BRNS: $1.31 vs. TARA: $3.11)
Brand notoriety: BRNS and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRNS: 2% vs. TARA: 42%
Market capitalization -- BRNS: $52.84M vs. TARA: $119.99M
BRNS [@Biotechnology] is valued at $52.84M. TARA’s [@Biotechnology] market capitalization is $119.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRNS’s FA Score shows that 1 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • BRNS’s FA Score: 1 green, 4 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, BRNS is a better buy in the long-term than TARA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRNS’s TA Score shows that 6 TA indicator(s) are bullish while TARA’s TA Score has 4 bullish TA indicator(s).

  • BRNS’s TA Score: 6 bullish, 5 bearish.
  • TARA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BRNS is a better buy in the short-term than TARA.

Price Growth

BRNS (@Biotechnology) experienced а -9.03% price change this week, while TARA (@Biotechnology) price change was -2.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.67%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +14.10%.

Reported Earning Dates

BRNS is expected to report earnings on Aug 07, 2025.

TARA is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+2.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARA($120M) has a higher market cap than BRNS($52.8M). BRNS YTD gains are higher at: 8.444 vs. TARA (-41.098). TARA has higher annual earnings (EBITDA): -51.1M vs. BRNS (-58.89M). TARA has more cash in the bank: 124M vs. BRNS (99.1M). TARA has less debt than BRNS: TARA (4.23M) vs BRNS (11.9M). BRNS has higher revenues than TARA: BRNS (15M) vs TARA (0).
BRNSTARABRNS / TARA
Capitalization52.8M120M44%
EBITDA-58.89M-51.1M115%
Gain YTD8.444-41.098-21%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash99.1M124M80%
Total Debt11.9M4.23M282%
FUNDAMENTALS RATINGS
TARA: Fundamental Ratings
TARA
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRNSTARA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 22 days ago
78%
Bullish Trend 30 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NPSGY2.15N/A
N/A
Nippon Sheet Glass Co., Ltd.
PPRQF10.45N/A
N/A
Choice Properties Real Estate Invt Trust
SPHRY0.65N/A
N/A
Starpharma Holdings Ltd.
NCSYF157.35N/A
N/A
NICE Ltd.
CAMNF0.12N/A
-0.77%
CASCADIA MINERALS LTD

BRNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRNS has been loosely correlated with SLNO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BRNS jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRNS
1D Price
Change %
BRNS100%
-5.07%
SLNO - BRNS
56%
Loosely correlated
-0.54%
NGNE - BRNS
51%
Loosely correlated
-0.75%
NEUP - BRNS
50%
Loosely correlated
+3.29%
IMVT - BRNS
48%
Loosely correlated
-3.33%
TARA - BRNS
35%
Loosely correlated
-1.27%
More

TARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with BRNS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
-1.27%
BRNS - TARA
34%
Loosely correlated
-5.07%
ITRM - TARA
32%
Poorly correlated
+0.66%
CDIO - TARA
31%
Poorly correlated
-1.01%
SQZB - TARA
30%
Poorly correlated
N/A
JANX - TARA
29%
Poorly correlated
-5.18%
More